| SOPHIA GENETICS SF -,05 |
| Schweiz |
| Gesundheit |
| CH1125843347 / A3CVT8 |
| 90B (Frankfurt) / SOPH (NASDAQ) |
| FRA:90B, ETR:90B, 90B:GR, NASDAQ:SOPH |
| - |
| https://www.sophiagenetic.. |
|
Sophia Genetics SA is a global leader in data-driv..
>Volltext.. |
| 289.25 Mio. EUR |
| 273.68 Mio. EUR |
| 63 Mio. EUR |
| -51.62 Mio. EUR |
| -64.45 Mio. EUR |
| -0.96 EUR |
| 54.47 Mio. EUR |
| 70.15 Mio. EUR |
| -35.08 Mio. EUR |
| 2.21 |
| 7.85% |
| 0.36% |
| - |
| - |
| - |
| - |
| SOPHIA GENETICS, SOPHIA GENETIC |
| 12.01.26 |
|